Edwards Rodney K, Tang Ying, Raglan Greta B, Szychowski Jeff M, Schulkin Jay, Schrag Stephanie J
Center for Women's Reproductive Health, University of Alabama at Birmingham, Birmingham, AL.
Center for Women's Reproductive Health, University of Alabama at Birmingham, Birmingham, AL.
Am J Obstet Gynecol. 2015 Aug;213(2):229.e1-7. doi: 10.1016/j.ajog.2015.03.047. Epub 2015 Mar 26.
The objective of the study was to evaluate attitudes and practice patterns of obstetricians related to screening for group B streptococcal colonization and providing intrapartum antibiotic prophylaxis against early-onset neonatal infections with group B streptococcus.
We mailed a survey to 546 members of the American College of Obstetricians and Gynecologists, including members of the Collaborative Ambulatory Research Network and non-Collaborative Ambulatory Research Network members. Stratified random selection was used to generate samples from both of these groups.
The survey response rate was 60% for Collaborative Ambulatory Research Network members and 42% for non-Collaborative Ambulatory Research Network members. Of the 206 respondents who reported providing prenatal care, 97% collect screening samples at 35-37 weeks' gestational age. Anatomic sites used to collect samples were more variable: 62% include lower vagina and rectum, 26% include lower vagina and perianal skin but not rectum, and 5% include neither the perianal skin nor the rectum. First-line agents for intrapartum antibiotic prophylaxis were penicillin (71%), ampicillin (27%), and cefazolin (2%). For patients reporting a nonanaphylactic penicillin allergy, drugs used for intrapartum antibiotic prophylaxis were more varied: cefazolin (51%), clindamycin (36%), vancomycin (8%), and erythromycin (5%). For patients undergoing a labor induction starting with a cervical ripening agent, less than 40% typically give the first dose of intrapartum antibiotic prophylaxis before or at the time of cervical ripening agent administration, and 15% wait until the patient reaches the active phase of labor.
Gaps in knowledge and reported practice related to the prevention of early-onset neonatal group B streptococcus infections were similar to gaps in implementation of guidelines demonstrated in past studies. New approaches to improve implementation are warranted.
本研究的目的是评估产科医生在筛查B族链球菌定植以及提供产时抗生素预防以预防早发性新生儿B族链球菌感染方面的态度和实践模式。
我们向美国妇产科医师学会的546名成员邮寄了一份调查问卷,其中包括协作门诊研究网络成员和非协作门诊研究网络成员。采用分层随机抽样从这两组中抽取样本。
协作门诊研究网络成员的调查回复率为60%,非协作门诊研究网络成员的回复率为42%。在206名报告提供产前护理的受访者中,97%在孕35 - 37周时采集筛查样本。采集样本的解剖部位差异较大:62%包括阴道下段和直肠,26%包括阴道下段和肛周皮肤但不包括直肠,5%既不包括肛周皮肤也不包括直肠。产时抗生素预防的一线药物为青霉素(71%)、氨苄西林(27%)和头孢唑林(2%)。对于报告有非过敏性青霉素过敏的患者,产时抗生素预防使用的药物更多样化:头孢唑林(51%)、克林霉素(36%)、万古霉素(8%)和红霉素(5%)。对于使用宫颈成熟剂开始引产的患者,通常不到40%的人在宫颈成熟剂给药前或给药时给予第一剂产时抗生素预防,15%的人会等到患者进入产程活跃期。
与预防早发性新生儿B族链球菌感染相关的知识和报告实践中的差距与过去研究中指南实施方面的差距相似。有必要采取新的方法来改进实施情况。